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INTRODUCTION
Performing epidemiologic studies for various rheumatic
diseases is difficult because of the expense associated with
confirming the diagnosis, their low prevalence, lack of spe-
cific diagnostic tests, and diverse manifestations (1). To over-
come these limitations, various types of questionnaires by
postal survey, telephone interview, and direct interview have
been developed for many rheumatic diseases, for example,
rheumatoid arthritis (RA), systemic lupus erythematosus
(SLE), osteoarthritis (OA), spondyloarthropathy, and connec-
tive-tissue diseases (1-5), and have proved to be useful instru-
ments for screening potential cases of various rheumatic dis-
eases. After screening via these questionnaires, the second test
of a clinical evaluation, laboratory tests, and/or radiologic eval-
uation can be used in epidemiologic studies for reducing the
false-positive rate of misclassifying healthy subjects as having
rheumatic diseases (1, 5). 
Epidemiologic studies for rheumatic diseases in Korea have
been rare. We therefore intended to develop a Korean rheumat-
ic diseases-screening questionnaire (KRSQ) for population
studies.
METHODS AND SUBJECTS
Development of the questionnaire
Based on American College of Rheumatology (ACR) cri-
teria for OA of the hand and knee (6, 7), and a connective-tis-
sue disease screening questionnaire (CSQ) for RA, SLE, scle-
roderma, polymyositis/dermatomyositis (PM/DM), Sjogren’s
disease, and mixed connective-tissue disease (MCTD) (1), a
Korean rheumatic disease questionnaire was constructed and
translated in Korean. The elements in the questionnaire for
knee OA were selected from clinical criteria (7). Among the
three questions for estimation of knee pain, the most sensi-
tive but least-specific question was selected for the OA ques-
tionnaire: “Have you ever had pain in or around the knee on
most days for at least a month? If so, have you experienced
any pain during the last year?”(8) The questionnaire consist-
ed of 31 items with yes/no responses.
Twenty consecutive patients were asked to rate each ques-
tion with regard to whether they understood and were famil-
iar with the task described (comprehensibility) by reflecting
their function on a 4-point scale (poor, 1; moderate, 2; good,
3; and very good, 4). We regarded each question as compre-
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A Korean Rheumatic Diseases Screening Questionnaire
The aim of our study was to develop a Korean rheumatic diseases-screening
questionnaire. The questionnaire was constructed based on American College
of Rheumatology criteria for rheumatic diseases and a connective tissue dis-
eases screening questionnaire. Two groups of patients were selected and com-
pleted the questionnaire: (i) those with osteoarthritis (n=46), rheumatoid arthritis
(n=52), systemic lupus erythematosus (n=50), scleroderma (n=8), polymyositis
or dermatomyositis (n=7), Sjogren’s disease (n=4), and mixed connective-tissue
disease (n=9) as case subjects; and (ii) those with fibromyalgia (n=8) and gen-
eral disease without evidence of any rheumatic disease (n=72) as controls. Lab-
oratory results were analyzed for correlation with actual data using kappa ( )
statistics. Test-retest reliability was performed in 12 patients, and showed strong
agreement between the first and second interviews (kappa=0.91). The sensitivi-
ty of the questionnaire ranged from 77.8 to 100%, and specificity ranged from
68.8 to 95.0%. Negative predictive values were very high in the general popula-
tion, from 98.4 to 99.99%. The  statistic for agreement between laboratory items
was 0.22-0.56, except for rheumatoid factor, antinuclear antibody test, and mus-
cle enzyme level. We have developed a simple and sensitive Korean rheumatic
diseases-screening questionnaire for the epidemiologic study of rheumatic dis-
eases in Korea.
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hensible when patients answered “3” or “4.” 
Identification of subjects
The case subjects with OA of the hand and/or knee (n=46),
RA (n=52), SLE (n=50), scleroderma (n=8), PM/DM (n=7),
Sjogren’s disease (n=4), or MCTD (n=9), and the control sub-
jects with fibromyalgia (n=8), were enrolled consecutively
from patients attending an outpatient clinic and those admit-
ted to the Hospital for Rheumatic Diseases, Hanyang Uni-
versity, Seoul, Korea. The diagnosis was confirmed by med-
ical record review for classification criteria (6, 7, 9-15). Patients
attending the outpatient clinic of family medicine at the same
hospital were recruited as another control group. This group
was free of rheumatic disease.
Data collection procedure
We used the method of direct interview for completing the
questionnaire, since our previous study on the Korean Health
Assessment Questionnaire (KHAQ) and the Korean West-
ern Ontario and McMaster University osteoarthritis index
found that self-assessed questionnaires may not be accurate
when answered by the elderly with poor levels of education
(16, 17). Some patients were asked to participate in the sec-
ond interview at least 6 months after the first one in order to
assess the test-retest reliability of the questionnaire. Demo-
graphic, socioeconomic, comorbid condition, and functional
status (class I includes the patients who can perform usual ac-
tivities of daily living completely; class II includes the patients
who can perform usual self-care and vocational activities but
limited in avocational activities; class III includes the patients
who can perform usual self-care activities but limited in
vocational and avocational activities; class IV includes the
patients limited in ability to perform usual self-care, voca-
tional, and avocational activities) (18) were obtained. 
Diagnostic criteria for identifying potential rheumatic
diseases
An algorithm for identifying potential patients with RA,
SLE, scleroderma, PM/DM, Sjogren’s disease, and MCTD
was made based on published criteria for connective-tissue
diseases (using the CSQ) (1). Our questionnaire was the same
as the CSQ except that it was adjusted to achieve the results
with a higher sensitivity and more acceptable range of speci-
ficity.
The criteria for RA were three (four in CSQ) of the follow-
ing six symptoms: morning stiffness for at least 1 hr and pre-
sent for at least 6 weeks; swelling of three of more joints for
more than 6 weeks; swelling of wrist, metacarpophalangeal
(MCP), or proximal interphalangeal (PIP) joints for more than
6 weeks; symmetric joint swelling; rheumatoid nodules; and
positive test results for rheumatoid factor (RF). Radiography
findings were not obtained. 
The criteria for potential SLE were three (four in CSQ) of
the following 12 items: malar rash, discoid rash, photosen-
sitivity, oral ulcers, arthritis, serositis, proteinuria, hemato-
logic disorder (i.e., anemia, leukopenia, or low platelet count),
positive antinuclear antibody (ANA) test, seizure, Raynaud’s
phenomenon, and hair loss. The last two questions, which
have high sensitivity but a lower specificity. Although they
were not included in ACR criteria (11), they were included
in the KRSQ because the goal of the epidemiologic study
was to develop an instrument with a higher sensitivity, rather
than a higher specificity. 
The criteria for scleroderma included two of the following
four items: skin thickening of arm, legs, face, neck, or trunk;
sclerodactyly or hand swelling; digital pitting scars; or pul-
monary fibrosis. 
The criterion for PM/DM was one of the following four
items: muscle weakness, upper-extremity proximal muscle
weakness, lower-extremity proximal muscle weakness for more
than 3 months, or a history of an elevated muscle enzyme level.
Criteria for Sjogren’s disease were dry eyes and mouth, or
positive serologic test results (ANA or RF) plus dry eyes or
mouth. 
Criteria for Raynaud’s phenomenon included white, blue,
or purple color changes of the fingers upon exposure to cold.
The classification of MCTD was based on two (four in CSQ)
of the following criteria: synovitis as defined by the RA algo-
rithm, hand edema, Raynaud’s phenomenon, myositis, or acro-
sclerosis. 
An algorithm for OA of the hand and knee was construct-
ed based on ACR clinical criteria for OA of hand and knee
(6, 7). Criteria for hand OA were hand pain (aching or stiff-
ness) and one of the following features: hand-tissue enlarge-
ment at two or more of the hand joints: PIP or distal inter-
phalangeal (DIP) joints, hard-tissue enlargement of two or
more DIP joints, fewer than three swollen MCP joints, and
deformity of at least one of the ten selected joints (6). Criteria
for knee OA were knee pain plus one of the following features
(7): age over 50 yr, morning stiffness for less than 30 min,
crepitus, bone tenderness, bone enlargement, or no palpable
warmth.
To confirm the reliability of the patient’s memory regard-
ing the laboratory findings (e.g., anemia, leukopenia, throm-
bocytopenia, proteinuria, RF, ANA, and muscle enzyme level)
and chest radiographic findings, we compared the patient’s
answers with actual data from the medical record review.
Statistical methods
A Student’s t-test was performed on the demographic vari-
ables of age, education, economy, and number of comorbid
conditions. A chi-square test or Fisher’s exact test was per-
formed on the categorized variables such as sex and function-
al status. The sensitivity (which is the proportion of positive
. .
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results from testing a group with a particular disease) and
specificity (which is the proportion of negative results in a
control group or a group without a particular disease) of the
questionnaire were calculated for each rheumatic disease.
The specificity of the questionnaire was also calculated for
the control group. Likelihood ratios (the ability of the test to
distinguish between diseased and nondiseased subjects) for all
control subjects combined were calculated as sensitivity/(1-
specificity). Positive and negative predictive values were
calculated as follows: 
The prevalence data used for the above calculation were
from the U.S.A. because no such data were available for
Korea (19): 12.1% for OA, 1% for RA, 0.1% for SLE,
0.025% for scleroderma, and 0.006% for PM/DM.  
We used kappa ( ) statistics to analyze the agreement be-
tween answering results of the laboratory findings and the
actual data from the medical record review. 
Test-retest reliability was evaluated with a kappa coefficient
that quantified the extent of agreement in the classification
of a subject as having any disease between two repeated admin-
istrations of the questionnaire. Agreement included classifi-
cation as one type of disease on the first administration and
another type of rheumatic disease on the second administra-
tion, and also the same rheumatic disease at both adminis-
trations. 
The results from the kappa analysis were interpreted as fol-
lows: 0.00, poor agreement; 0.01-0.20, slight agreement;
0.21-0.40, fair agreement; 0.41-0.60, moderate agreement;
0.61-0.80, substantial agreement; and 0.81-1.00, almost per-
fect agreement (20). 
The specificity of the questionnaire for each rheumatic dis-
ease was evaluated for subsets of respondents stratified by age
(≤50 yr vs >50), educational (education year ≤12 vs >12),
functional status (class I and II vs III and IV), and socioeco-
nomic characteristics (monthly income ≤200×10
4 vs >
200×10
4 Korean won [=1,670 US $] according to the mean
value in study subjects).
RESULTS
Characteristics of the study population
Subjects participating in the questionnaire interview includ-
ed the patients with hand and/or knee OA (n=46), RA (n=52),
SLE (n=50), scleroderma (n=8), PM/DM (n=7), Sjogren’s
syndrome (n=4), MCTD (n=9), fibromyalgia (n=8), and gen-
eral medical conditions (n=72) (Table 1).
Test-retest reliability
Test-retest reliability for detection of any potential rheumat-
ic disease was performed in 12 patients. Eleven (91.7%) of
them were classified as having a rheumatic disease at the first
and second interview (kappa=0.91).
Kappa statistic for laboratory questions
The kappa statistics for questions regarding laboratory and
radiographic findings were 0.22-0.56, indicating fair-to-mod-
erate agreement in general. However, some exhibited a poor
kappa values: 0.08 for RF, -0.27 for ANA, and 0.18 for CPK
(Table 2). 
Sensitivity and specificity
The sensitivity of the questionnaire ranged from 77.8 to
100%: 91.3% for OA, 78.9% for RA, 88.0% for SLE, 87.5%
Mean age (SD)
(yr) 50.6 (15.2) 46.4 (10.9) 49.3 (14.1)
Mean education 
(SD) (yr) 11.5 (3.9) 11.7 (3.8) 11.6 (3.9)
Mean number 
of comorbid 
conditions 
(SD) 2.1 (0.99) 1.4 (0.79)       1.87 (0.99)
Female, % 92.6 52.5 80.1
Characteristics
Table 1. Characteristics of the study population
All rheumatic patients* 
(n=176 )
All control patients
�
(n=80)
Total
(n=256)
*Includes patients with osteoarthritis (OA), rheumatoid arthritis (RA),
systemic lupus erythematosus (SLE), scleroderma, polymyositis/der-
matomyositis (PM/DM), Sjogren’s syndrome, and mixed connective tis-
sue disease (MCTD). 
� Includes patients with fibromyalgia and patients
attending an outpatient clinic of family medicine.
Anemia 0.22*
Leukopenia 0.30*
Thrombocytopenia 0.56*
Proteinuria 0.43*
Antinuclear antibody                                                                      -0.27
Rheumatoid factor 0.08
Pulmonary fibrosis 0.53*
Muscle enzyme 0.18
Table 2. The kappa statistics for agreement between labora-
tory and radiographic questions
Laboratory and radiologic items Kappa
*p<0.05.
. .
. .
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for systemic sclerosis, 85.7% for PM/DM, 100% for Sjogren’s
disease, and 77.8% for MCTD. The specificity ranged from
68.8 to 95.0%: 75.0% for OA, 95.0% for RA, 72.5% for
SLE, 71.3% for systemic sclerosis, 68.8% for PM/DM, 95.0%
for Sjogren’s disease, and 91.3% for MCTD. Likelihood ratios
ranged from 2.7 to 20: 3.7 for OA, 15.8 for RA, 3.2 for SLE,
3.0 for systemic sclerosis, 2.7 for PM/DM, 20 for Sjogren’s
disease, and 8.9 for MCTD (Table 3).
Stratified analysis of specificity by demographic, socioeco-
nomic, and functional status was performed (Table 4). We
found significantly lower specificity for OA among older sub-
jects (>50 yr), and for RA and SLE among subjects with poor
functional status (class=III or IV).  
Predictive values
Positive predictive values in the general population ranged
from 0.02 to 33.2%: 33.2% for OA, 13.7% for RA, 0.32%
for SLE, 0.025% for systemic sclerosis, and 0.02% for PM/
DM. Negative predictive values were very high, ranged from
98.4 to 99.99% in the general population: 98.4% for OA,
99.8% for RA, 99.98% for SLE, 99.99% for systemic scle-
rosis, and 99.99% for PM/DM (Table 5). 
DISCUSSION
We have developed the KRSQ based on ACR criteria for
various rheumatic diseases and the CSQ, and analyzed the
sensitivity, specificity, and positive and negative predictive
values of this new questionnaire. The sensitivity and speci-
ficity of each disease were found to be high in general. Neg-
ative predictive values for any disease were very high, rang-
ing from 98.4 to 99.99%.
Osteoarthritis is the most common type of arthritis, and
the second only to chronic heart disease as the primary diag-
nosis leading to adults receiving social security disability pay-
ments in the U.S.A. (19). The prevalence of OA is certain to
increase as the number of elderly people increases. In contrast
to OA, the other rheumatic diseases were characterized by a
low prevalence, and diverse manifestations, and expensive tests
(e.g., for ANA) for diagnosis. 
Epidemiologic studies on the prevalence of OA and con-
nective tissue diseases have been performed worldwide (21-
27). Such studies have used interview and examinational sur-
veys with or without radiographic studies. Radiographic stud-
ies provide data that are more precise and useful, but they are
more expensive to perform (1). Therefore, it might be diffi-
cult to perform this type of expensive and large epidemiolog-
ic study in countries such as Korea that have relatively low
percapita GDPs. Therefore, the development and application
OA Hand (n=4)                       100 75.0 4.0
Knee (n=23) 78.3 90.0 7.8
Hand and knee (n=46) 91.3 75.0 3.7
RA (n=52) 78.9 95.0 15.8
SLE (n=50) 88.0 72.5 3.2
Scleroderma (n=8) 87.5 71.3 3.0
PM/DM (n=7) 85.7 68.8 2.7
Sjogren’s disease  (n=4)        100 95.0 20
MCTD (n=9) 77.8 91.3 8.9
Table 3. The sensitivity, specificity, and likelihood ratio of the
Korean rheumatic diseases screening questionnaire (KRSQ)
Rheumatic 
disease
Sensitivity 
(%)
Specificity 
(%)
Likelihood 
ratio
. .
OA 12.1 33.2 98.4
RA 1.0 13.7 99.8
SLE 0.1 0.32 99.98
Scleroderma 0.025 0.08 99.99
PM/DM 0.006 0.02 99.99
*These values are based on U.S.A. data (19).
Table 5. Prevalence and predictive value (PV) percentages by
disease for the general population
Prevalence* (%) Positive PV (%) Negative PV (%)
OA 75.0 Age >50 yr 63.6*
Education <12 yr 70.4
Low income
� 74.4
Functional class ≥III 66.7
RA 95.0 Age >50 yr 96.9
Education <12 yr 92.6
Low income 95.3
Functional class ≥III 75.0*
SLE 72.5 Age >50 yr 81.8
Education <12 yr 74.1
Low income 67.4
Functional class ≥III 33.3*
Scleroderma 71.3 Age >50 yr 84.8*
Education <12 yr 72.2
Low income 65.1
Functional class ≥III 66.7
PM/DM 68.8 Age >50 yr 78.8
Education <12 yr 70.4
Low income 62.8
Functional class ≥III 66.7
Sjogren’s 95.0 Age >50 yr 96.9
Disease Education <12 yr 94.4
Low income 95.4
Functional class ≥III 83.3
MCTD 91.3 Age >50 yr 93.9
Education <12 yr 90.7
Low income 88.4
Functional class ≥III 75.0
Table 4. Specificity of the KRSQ after stratification by demo-
graphic and functional status
Specificity (%) Subgroup Specificity (%)
. .
*p<0.05. 
� Low income means monthly income≤200×10
4 Korean
won [=1,670 US $] according to the mean value in study subjects.
. .
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of a questionnaire with high sensitivity and specificity to epi-
demiologic studies would be more useful for population stud-
ies under these conditions (1, 5). Since the use of the data based
on only self-reported cases presents some limitations, we con-
structed the questions based on the available reports published
on this subject. We used the CSQ that was shown to be high-
ly sensitive and specific for screening potential connective-tis-
sue diseases (1), and adjusted the algorithm to Korean circum-
stances in order to achieve better results.
There have been a few reports validating postal surveys for
self-reported OA or asking about the presence of any nodes
of the hand joints such as PIP and DIP joints (28-31). Based
on these studies and ACR criteria, questions for hand OA in
our study included the presence of pain, hard-tissue enlarge-
ment, and deformity of hand joints. It is well known that the
estimates of knee pain are influenced by even minor changes
in question content (8). In one study that compared three ques-
tions for knee pain, the ACR-criteria question was relatively
insensitive for use in the community, and the following ques-
tion was found to be the most sensitive but least specific:
“Have you ever had pain in or around the knee on most days
for at least a month? If so, have you experienced any pain dur-
ing the last year?”(8). Therefore, we chose this question for
verifying the presence of pain, and added the presence of crepi-
tus, bone tenderness, bone enlargement, morning stiffness for
less than 30 min, and no palpable warmth in the question-
naire for knee OA based on ACR criteria (7). 
The initial results using the original CSQ algorithm and
strict criteria for the OA questionnaire showed high specifici-
ty rather than high sensitivity (1, 6, 7). Since the goal of this
questionnaire was to develop the tools that can find the largest
number of cases, we changed the algorithm to get the results
with high sensitivity, high negative predictive value, and an
acceptable range of specificity. 
We investigated the reliability of the questions of labora-
tory or radiographic findings. Questions for anemia, leuko-
penia, thrombocytopenia, proteinuria, and pulmonary fibro-
sis showed fair-to-moderate agreement, but the agreement
of questions for RF, ANA, and muscle enzyme level was so
poor that these questions were considered not to be useful in
Korean population studies. To get more precise results,
therefore, it is recommended that KRSQ should be accom-
panied with or followed by laboratory tests. 
A large national population study into health and nutri-
tional status is conducted by interview survey tri-annually
in Korea. According to data from the most-recent study
(1998), the prevalence of arthritis in the total population was
8.0% (female 12.9%, male 4.3%), and it occurs in 24.5%
of people older than 45 yr. Although that study provided
valuable data from a large population, and was certainly a
well-designed study, it had some limitations. The study used
a ‘self-reported’ questionnaire asking only about the presence
or absence of arthritis: “Have you ever had arthritis”. It was
not considered whether the diagnosis of disease was made
by a doctor or not, and what was the disease subcategory (e.g.,
OA, RA, or SLE). Therefore, future large national population
surveys in Korea should be designed to overcome these limi-
tations. Screening the patients with potential disease should
be followed by the second step comprising a physician’s physical
examination, and laboratory and radiographic tests for reducing
false-positive results.
Our study had some limitations, including a small number
of patients especially in the case of rare connective-tissue dis-
eases such as scleroderma, PM/DM, Sjogren’s disease, MCTD,
and hand OA without knee OA. The number of control pa-
tients, especially patients with fibromyalgia, was also small.
Furthermore, test-retest reliability was performed on a small
number of patients. To obtain precise information and to con-
firm the usefulness of the KRSQ in population studies, the
continuous enrolling of many more cases is needed.
In summary, we propose this KRSQ for epidemiologic study
of the various rheumatic diseases in Korea. The questionnaire
had high sensitivity, moderate specificity, and a high nega-
tive predictive value. 
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1. 3개월 이상 관절염이 지속된 적이 있었습니까?
2. 아침에 자고 일어났을 때 관절이 뻣뻣한 증상이 6주 이상 지속된 적이 있었습니까?
1-1 만약‘예’ 로 답하셨다면 그 증상이 얼마나 지속됩니까?
○ 30분 이내에 좋아진다.
○ 1시간 이상 지속된다.
1-2 어느 관절에 상기 증상이 생깁니까? 
3. 팔꿈치 관절이나 발목 관절 주위의 피부에 약간 튀어 오르거나 혹 같은 결절이 있었던 적이 있었습니까?
4. 손목 관절, 손가락 관절(단, 손가락 끝마디는 제외), 팔꿈치 관절, 무릎 관절 중에서 6주 이상 붓고 통증이 지속되었던 적이 있으면 다음 그림에 표
시를 해주십시오.
5. 류마티스 관절염에 대한 피검사를 해보신 적이 있었습니까?
5-1 만약‘예’ 로 답하셨다면 결과가 어떻게 나왔습니까? 
6. 루푸스에 대한 피검사를 해보신 적이 있었습니까?
6-1 만약‘예’ 로 답하셨다면 결과가 어떻게 나왔습니까?
7. 손가락을 추운 날씨에 노출시키거나 차가운 물에 담갔을 때 피부 색깔이 변합니까?
7-1 만약‘예’ 로 답하셨다면 어떤 색깔로 변했습니까?
8. 입안이나 코안이 2주 이상 헐었던 적(궤양)이 있었습니까?
9. 양 쪽볼위 에붉 은색발 진 이한달이 상지 속 된적 이있었습니까?
10. 햇볕에 노출 시 남들과는 달리 심하게 피부가 빨갛게 되거나 물집이 생기거나 가렵고 쓰라린 적이 있었습니까?
11. 심호흡을 할 때 가슴이 결리듯이 아파서 숨쉬기가 힘들었던 경험이한달이 상지속되었던 적이 있었습니까?
12. 원인 없이 머리카락이 이전보다 훨씬 심하게 빠졌던 적이 있었습니까?
13. 경기나 간질 등을 한 적이 있었습니까? 
14. 건강 검진이나 신체 검사 등을 비롯한 지금까지 했던 피검사에서 다음과 같은 진단을 받은 적이 있었습니까?
① 빈혈이 있다
② 백혈구 수가 떨어져 있다
③ 혈소판 수가 떨어져 있다
APPENDIX 류마티스 질환 유병률 조사를 위한 설문조사지④ 소변에 단백질이 나온다(단백뇨)
⑤ 피부에 원판상 루푸스가 있다
⑥ 폐섬유화로 진단 받았다
⑦ 근육효소가 상승되어 있다
15. 지금까지 한 번이라도 무릎관절이나 그 주위가한달이 상지속적으로 아픈 적이 있었습니까?
15-1 만약‘예’ 로 답하셨다면 최근 1년 사이에도 무릎이나 무릎 주위의 통증이 있었습니까? 
16. 무릎을 움직일 때 소리가 납니까?  
17. 무릎관절이 옛날에 비해서 더 딱딱하게 튀어나왔습니까? 
18. 무릎관절을 손으로 만져보았을 때 열이 있습니까?
19. 무릎관절을 손으로 눌렀을 때 아픕니까?
20. 손가락 마디가 아팠던 적이 있습니까?
21. 손가락 마디 중 딱딱하게 튀어나온 것이 있습니까?
21-1 만약 있으면 다음 그림에 표시해 주십시오.
22. 손가락 관절 중에서 딱딱하게 튀어나오면서 변형이 된 것이 하나라도 있습니까?
22-1 만약 있으면 다음 그림에 표시해 주십시오.
23. 한 달 이상 손이 전체적으로 심하게 부었던 적이 있었습니까?
24. 팔, 다리, 얼굴, 목이나 또는 몸의 피부가 딱딱해지거나 조이는 듯한 느낌이 있었던 적이 있습니까?
25. 손가락이나 발가락의 피부가 딱딱해진 적이 있습니까?
26. 손가락 끝에 궤양과 함께 그로 인한 상처가 생겼던 적이 있습니까?
27. 3개월 이상 근육의 힘이 없었던 적이 있습니까?
28. 3개월 이상 앉았다가 일어나기가 힘들 정도로 다리근육의 힘이 없었던 적이 있었습니까? 
29. 3개월 이상 머리 빗기가 힘들 정도로 팔근육의 힘이 없었던 적이 있었습니까?
30. 눈물이 안 나와서 눈이 뻑뻑하고 모래가루가 있는 것처럼 불편한 적이 있었습니까
31. 잠을 자다가 일어나서 물을 마셔야 할 정도로 입이 마른 적이 있었습니까?
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